Assessment of glycemic lability and severity of hypoglycemia in korean patients with type 1 diabetes

Endocrine Journal

Volumn 58, Issue 6, 2011, Pages 433-440

  Kim, Soo Kyoung ^a   Kwon, Soon Beom ^a   Yoon, Kun Ho ^b   Ahn, Kyu Jeung ^c   Kang, Jun Goo ^d   Jung, Hye Seung ^e   Kang, Eun Seok ^f   Kim, Jae Hyeon ^a   Kim, Kwang Won ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Kyung Hee University   (South Korea)

^d Hallym University   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

Author keywords

Glycemic lability; Hypoglycemia; Type 1 diabetes mellitus

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC LABILITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; SELF MONITORING; TERTIARY HEALTH CARE; TREATMENT RESPONSE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; KOREA; MALE;

EID: 79959983174     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K11E-014     Document Type: Article

References (28)

1. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE (2006) Pancreas and islet transplantation in type 1 diabetes. Diabetes Care 29(4): 935.
2. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238.
3. Kendall DM, Rooney DP, Smets YF, Salazar Bolding L, Robertson RP (1997) Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 46: 249-257.
4. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M; GRAGIL Group (2002) Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Diabetes Care 25: 2256-2262.
5. Yang TY, Oh SH, Jeong IK, Seo IA, Oh EY, Kim SJ, Chung JH, Min YK, Lee MS, Lee MK, Kim KW, Do YS, Choo SW (2002) First human trial of pancreatic islet allo-transplantation in Korea-focus on re-transplantation. Diabetes Res Clin Pract 56: 107-113.
6. Park JW, Ha J, Lee JH, Kang JM, Jung SK, Kim EM, Lee HS, Kim YS, Cho YM, Park KS, Ahn C, Kim SJ (2006) Experience of Simultaneous Pancreas and Kidney Transplantation in Seoul National University Hospital. J Korean Soc Transplant 20: 181-186.in Korean.
7. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC (2004) Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 53: 955-962.
8. Kilpatrick ES, Rigby AS, Atkin SL (2009) Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 32: 1901-1903.
9. Monnier L, Colette C, Owens DR (2008) Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2: 1094-1100.
10. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644-655.
11. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W (2006) Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29: 2433- 2438.
12. Ryan EA, Bigam D, Shapiro AM (2006) Current indications for pancreas or islet transplant. Diabetes Obes Metab 8: 1-7.
13. Rodbard D (2009) New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 11: 551-565.
14. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W (1995) Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18: 517-522.
15. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young- Hyman D, Schlundt D, Clarke W (1998) Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 21: 1870-1875.
16. Cox DJ, Kovatchev BP, Julian DM, Gonder-Frederick LA, Polonsky WH, Schlundt DG, Clarke WL (1994) Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J Clin Endocrinol Metab 79: 1659-1662.
17. Ko KW, Yang SW, Cho NH (1994) The incidence of IDDM in Seoul from 1985 to 1988. Diabetes Care 17: 1473-1475.
18. Tajima N, LaPorte RE, Hibi I, Kitagawa T, Fujita H, Drash AL (1985) A comparison of the epidemiology of youth-onset insulin-dependent diabetes mellitus between Japan and the United States (Allegheny County, Pennsylvania). Diabetes Care 8: 17-23.
19. Moberg EA, Lins PE, Adamson UK (1994) Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens. Diabete Metab 20: 546-552.
20. Lemozy-Cadroy S, Crognier S, Gourdy P, Chauchard MC, Chale JP, Tauber Dagger JP, Hanaire-Broutin H (2002) Intensified treatment of type 1 diabetes: prospective evaluation at one year of a therapeutic patient education programme. Diabetes Metab 28: 287-294.
21. Rodbard D (2007) Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Technol 1: 62-71.
22. Greven WL, Beulens JW, Biesma DH, Faiz S, de Valk HW (2010) Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study. Diabetes Technol Ther 12: 695-699.
23. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM (1990) Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 7: 711- 717.
24. The Diabetes Control and Complication Trial Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90: 450-459.
25. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group (2010) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 363: 311-320.
26. Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC, Najarian JS (2001) Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 233: 463- 501.
27. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard T (2010) All-cause mortality trends in a large population-based cohort with long-standing childhoodonset type 1 diabetes: the allegheny county type 1 diabetes registry. Diabetes Care 33: 2573-2579.
28. Hamman RF (2010) Mortality risk in long-standing type 1 diabetes: hope and concern. Diabetes 59: 2997-2998.